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E-mail address: stefania.rubrichi@unipv.it (S. RubrThe use of medications has a central role in health care provision, yet on occasion, it may injure the
person taking them as result of adverse drug events. A correct drug choice must be modulated to
acknowledge both patients’ status and drug-speciﬁc information. However, this information is locked
in free-text and, as such, cannot be actively accessed and elaborated by computerized applications.
The goal of this work lies in extracting content (active ingredient, interaction effects, etc.) from the
Summary of Product Characteristics, focusing mainly on drug-related interactions, following a machine
learning based approach. We compare two state of the art classiﬁers: conditional random ﬁelds with
support vector machines. To this end, we introduce a corpus of 100 interaction sections, hand annotated
with 13 labels that have been derived from a previously developed conceptual model. The results of
our empirical analysis demonstrate that the two models perform well. They exhibit similar overall
performance, with an overall accuracy of about 91%.
 2011 Elsevier Inc. All rights reserved.1. Introduction
Adverse drug events (ADEs) have been deﬁned as injuries
resulting from medical intervention related to a drug [1] that
endanger patient’s safety and account for increased heath care
costs. Examples include injuries (e.g., rash, confusion, or loss of
function) caused by incorrect dosage as well as allergic reactions
occurring in a patient not known to be allergic to a given medica-
tion and so forth. Many of these injuries suffered by patients are
inevitable but at least a quarter may be secondary to medication
errors [2], as errors in medication-management process are gener-
ally called [3]. These damages are not unavoidable and can be pre-
vented. According to one estimate, medication errors occur most
frequently at the prescribing and administration stages [2]. The
rate of medication errors and preventable ADEs represents a seri-
ous cause for concern. The Institute of Medicine (IOM) committee,
in its report Preventing Medication Error, estimates that more than
1.5 million ADEs are preventable each year in the US alone [2]. This
report outlines the main priorities for research on safe medication
use that will address this problem. It proposes electronic prescrib-
ing, by computerized provider order entry (CPOE) systems, as one
of the most highly effective error prevention strategies.
CPOE systems are computer applications that allow direct, elec-
tronic entry of orders formedications, laboratory, radiology, referral,
and procedures [4]. Several systematic reviews have shown the
beneﬁts of CPOE systems [5–10] resulting fromtheir ability to detect
unsafe and potentially fatal medication orders. Computerization inll rights reserved.
ichi).fact enables the delivery of clinical decision support [11], alerts to
guide ordering, allowing for checks for allergies, drug–drug interac-
tions, clinical conditions.One of the factors,whichmainly inﬂuences
the overall performance of such a system, is the quality and validity
of the knowledge base underlying the system. Safe medication
use requires that providers and consumers synthesize several types
of information, including knowledge of themedication itself, aswell
as understanding of how it may interact with coexisting illnesses
andmedications, andhow its usemight bemonitored. This informa-
tion is constantly changing, andwhilemost of thenecessaryupdated
knowledge is available somewhere, it is not always readily accessi-
ble, creating a situation in which it is almost impossible for health
care providers to have current knowledge of every medication they
prescribe.
In this work, we consider the problem of automatic extraction
of drug information conveyed in the Summary of Product Charac-
teristics (SPC), focusing on a speciﬁc section concerned with
drug-related interactions. Our contributions are as follows:
1. We formulate the problem in a machine learning framework, in
which we seek to assign the correct semantic label, such as
InteractionEffect or ActiveDrugIngredient, to each word, or seg-
ment of sentence, of the text. We employ two state of the art
classiﬁers: linear-chain conditional random ﬁelds (CRFs) and
structural support vector machines (SVMs). These classiﬁers
discriminate between semantically interesting and uninterest-
ing content through the automatic adaptation of hundreds of
engineered text characteristics, taking into account the proper-
ties of a document, on both a local (word) and global (sentence)
level.
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language that have been annotated with 13 distinct semantic
labels, with respect to a previously implemented ontology.
3. We apply the CRFs and the SVMs to our data set and evaluate
their overall and individual label results. Both the classiﬁers
achieve a micro-averaged F1-measure (see Section 4.2) greater
than 90%, which is promising for real-world applications.
In a next step, the extracted information will be used to popu-
late the ontology, in order to carry out automated reasoning on
data. This reasoning process could help, for example, to determine
whether it is possible for a particular drug to have any interaction
with a particular active ingredient or diagnostic test, to ﬁnd the ef-
fect of a particular interaction and so on. Moreover, ontology pop-
ulation can compensate for the possible lack of completeness and/
or congruence among different SPCs. Like this, such knowledge
model can be made available to speciﬁc prescription applications,
such as CPOE, for integrating the underlying base of knowledge,
thus improving the prescription process.2. Background
SPCs represent a vast source of information for health profes-
sionals on how to use medicines safely and effectively. It forms
an intrinsic and integral part of marketing authorization. In order
to obtain an authorization to place a medicinal product on the mar-
ket, a SPC shall be included in the application made to the compe-
tent authority. A SPC lays out the agreed position (results of
physico-chemical, biological or microbiological tests, toxicological
and pharmacological tests, clinical trials, etc.) on the medicinal
product as collected during the course of the assessment process.
Its content is regulated by Article 11 of Directive 2001/83/EC.
Accordingly, SPCs of specialty medicines for human use are
organized into 12 sections: name, therapeutic categories, active
ingredient, excipients, indications, contraindication/side effects,
undesired effects, posology, storage precautions, warnings, interac-
tions, and use in case of pregnancy and nursing.
All this information is locked in free-text, the most convenient
and natural way to convey medical knowledge for human commu-
nication [12]. This narrative form, however, cannot be actively
used by health information systems. Reliable access to this com-
prehensive information, by Natural Language Processing (NLP)
systems, can provide a wide range of coded data [12,13]. Such data
will then be available for new or enriched clinical applications,
thus facilitating and improving the prescription process. It is there-
fore an important aspect for improving quality of care and prevent-
ing medication errors.
Among NLP techniques, information extraction (IE) methods
have been largely employed in the biomedical domain to extract
facts from free-text [14–18] and to make them available for subse-
quent tasks such as case ﬁnding, summarization, decision support,
or statistical analysis.
In this work, we therefore propose to extract drug-related inter-
action information reported in SPC, following a named entity
recognition (NER) approach. NER is an important step in an integral
IE task and aims at identifying words or phrases in natural lan-
guage text belonging to certain classes of interest (i.e., Named Enti-
ties), such as diseases or drugs, and labeling them with their
appropriate type [19]. In NER, an attempt will be made to associate
each token with a label that indicates its appropriate domain-
speciﬁc category. Approaches to NER span a broad range, from
rule-based systems to machine learning. Rule-based systems make
decisions on sets of hand-written disambiguation rules that play
an important role in discovering a named entity, which specify,
for example, that an ambiguous word belongs to a particularnamed entity rather than to another one if it follows another spe-
ciﬁc named entity.
On the other hand, a typical application of machine learning
works to classify a novel instance x as belonging to a particular
class y. In the ﬁeld of label sequence problems such techniques
aim at identifying the most likely sequence of labels for the words
in any given sentences. These methods generally resolve tagging
ambiguities by using training corpus to compute the probability
of a given word having a given tag in a given context. Then, they
automatically tune their own parameters to maximize their perfor-
mance on the training corpus. The machine then generalizes from
these samples.
Rule-based NER systems can be very effective but require some
manual effort. Machine learning approaches can successfully ex-
tract named entities but require large annotated training data.
Advantages of machine learning approaches are that they do not
require human intuition, they are general and clearly separate
the algorithm from the data, so that it is easier to apply them to
any domain by simply retraining without reprogramming.
2.1. Related work
Several studies have addressed the issue of IE in medication do-
main. Some approaches concentrated their analysis on the extrac-
tion of drug names. Levin et al. [20] implemented a system based
on lexicon (RxNorm) and regular expressions (Hints List) to extract
and normalize drug names from an anesthesia electronic health re-
cord, into a standardized terminology. RxNorm and Hints List con-
cepts were used in the mapping module as references for drug
names, and medical abbreviations and jargon, respectively. In an-
other study, Sirohi and Peissig [21] performed a dictionary-based
NLP study to determine the effects of using varying lexicon to ex-
tract drug names from electronic medical records. These authors
have shown how the accuracy of results can be enhanced by reﬁn-
ing the drug lexicon.
Other studies focus on extracting more speciﬁc drug features,
such as drug names and dosage. In one example, Evans et al. [22]
reported a method of extracting drug and dosage data from a col-
lection of discharge summaries. They ﬁrst draw a conceptual mod-
el of drug-dosage information and then identiﬁed this information
using a semantically driven extraction module. This module com-
bines readily available NLP facilities from the Clarit system with
newly created resources, including a set of pattern rules and a lex-
icon. A study by Shah and Martinez [23] derived numerical infor-
mation about daily dosage from unstructured dosage instructions
from a patient records database, using a dictionary to standardize
words and phrases. Then, they converted the extracted information
into structured ﬁelds.
Lately, more studies have been geared toward the extraction of
a more complete set of drug characteristics. In particular, Gold et
al. [24] built Merki, a parser that can extract drug names and other
relevant information from discharge summaries using a lexicon
and a set of parsing rules. Evaluation showed that the system
identiﬁed drug names, but other information such as dose and fre-
quency had lower precisions. Similarly, Xu et al. [25] implemented
a NLP system, MedEx, which extracts medication information from
clinical notes. Relying on a more detailed medication representa-
tion model, they integrated a semantic tagger and Chart parser to
capture drug names and signature information from clinical narra-
tives and then to map it onto structured representation.
The Third i2b2 NLP Challenge [26] focused on the extraction of
medication information, in particular medication names, dosages,
routes of administration, frequencies, durations, and reasons for
administration, from discharge summaries. Different approaches
have been proposed to address this task: rule-based,machine learn-
ing, and hybrid systems. Among others, Doan et al. [27] integrated
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ary detection program, a section identiﬁcation program (SecTag),
the MedEx system for tagging medication ﬁelds, and ﬁnally a con-
text-free grammar for converting the text into a structured format.
Tikk and Solt [28] proposed an approach in three steps: NER, context
ﬁltering, and relation extraction.While the last two components are
rule-based, for NER, they investigated ﬁrst a rule-based and second
a CRFs-based method, which, with enough large training data,
showed considerably better performance. Meystre et al. [29] em-
ployed a hybrid system, between machine learning and rule-based,
called Textractor.
On the whole, current works focus on clinical text narrative.
However, Pereira et al. [30] considered another source of informa-
tion on medications, namely SPCs, and thus addressed the problem
of automatic indexing. The authors developed a method to auto-
matically generate a dictionary for use with a French Multi-Termi-
nology Indexing tool.
Only a few published papers address the issue of extracting
drug interactions information from narrative text. Segura-Bedmar
et al. [31] employed a kernel-based approach that uses SVMs
aiming at detecting drug–drug interactions. A more detailed anal-
ysis of such work and a comparison with our own are presented in
Section 5.3. Methods
As we have already stated, we developed a framework for
simultaneously recognizing occurrences of multiple entity classes
using linear-chain CRFs and structured SVMs. Both of these two
supervised machine learning approaches predict words’ labels by
using a large number of interdependent descriptive characteristics
(features) of the input by assigning real-valued weight to these
features.
Presented here is an outline of our framework. We propose an
approach in ﬁve steps. We began by deﬁning a semantic represen-
tation model of drug information conveyed in the SPCs, in order to
ﬁnd out the concept to be extracted. In a second step, a preprocess-
ing pass was required for preparing the dataset for the use by the
extraction module. Then, we annotated the text by hand, with re-
spect to the previously developed conceptual model. Subsequently,
we deﬁned a set of binary features that express some descriptive
characteristics of the data, for instance ‘‘current token is capital-
ized’’. Finally, we processed the data through the two discrimina-
tive models (CRFs and SVMs): both the algorithms iterate the
tokens in the sentence, and label proper tokens with semantic la-
bels, by learning the correspondence between labels and features.3.1. Conceptual model
Typically, the ﬁrst step in most NER tasks is to identify the
named entities (labels) that are relevant to the concepts, relations,
and events described in the text. A system for NER is thus based
upon speciﬁc knowledge about the domain. Therefore, as part of
the understanding of the text factual information process, we
had previously developed a formal model of drug information con-
veyed in the SPCs. We conducted a manual analysis of SPCs text so
as to identify the underlying semantic concept classes (i.e., con-
cepts representing drug features) and semantic relationships
among those concepts. This analysis has resulted in a domain
ontology of medication [32], the formal means of representing
domain-speciﬁc knowledge. In particular, in this study, we focused
on drug interactions, then we looked, more speciﬁcally, at the 12
concepts that properly model drug interaction ﬁndings. A partial
view of the implemented ontology, concerned with drug-related
interactions, is presented in Fig. 1.Generally, a drug interaction represents the situation in which a
substance affects the activity of an active ingredient, resulting in
various effects such as alterations in absorption, metabolism,
excretion, and pharmacodynamics (i.e., the drug effects are de-
creased or increased, or the drug produces a new effect that neither
produces on its own). Typically, interaction between active ingre-
dients comes to mind. However, interactions may also exist
between drugs and foods, as well as drugs and herbs. Moreover,
some interactions can be abstracted at a drug class level. Eventu-
ally, an interaction can occur under particular contexts, and in
the presence of particular treatment conditions (such as dosage,
intake route). All this information is made explicit in the ontology
by the relations ‘‘with’’, ‘‘produces’’ and ‘‘under condition’’. The ﬁrst
links the class ‘‘Interaction’’ to the classes ‘‘Active Drug Ingredient’’,
‘‘Drug Class’’ and ‘‘Other Substance’’ to deﬁne the substance
interfering. The second links the class ‘‘Interaction’’ to the classes
‘‘Interaction Effect’’, while the latter links ‘‘Interaction’’ with
‘‘Personal Condition’’, ‘‘Posology’’ and ‘‘Intake Route’’, in order to
deﬁne the conditions potentially leading to the occurrence of the
interaction effect.3.2. Preprocessing step
As long as the label prediction is on a word-by-word basis, and
decisions are made for one sentence at a time, the ﬁrst stage of our
extraction algorithm consists in splitting the text of SPC interaction
section into sentences and then to break those input sentences into
tokens. We used full stops and white spaces to determine sentence
and token boundaries, respectively. Moreover, in order to account
for exceptions, we considered a normalization steps that mainly in-
cludes removing all punctuation but colon and brackets, adding
white spaces between colon and brackets, and the previous word,
removing hyphens if they exist between alphanumeric strings,
replacing dots that occur between numbers as decimal mark,
(‘‘4.5’’) with commas (‘‘4,5’’).3.3. Annotation process
The annotation process was performed by a biomedical engi-
neer with domain knowledge. Semantic annotation is used to
establish links between the entities in the text and their semantic
descriptions or concept classes in the above described ontology.
We used the following 13 semantic labels: ActiveDrugIngredient,
AgeClass, ClinicalCondition, DiagnosticTest, DrugClass, IntakeRoute,
OtherSubstance, InteractionEffect, Posology, PharmaceuticalForm,
PhysiologicCondition, RecoveringAction, None. The latter has been gi-
ven to indicate elements that are not relevant for this research.
Leveraging the established ontology, we mapped its elements to
the SPCs’ text content. We carefully inspected all the corpus lines
distinguishing the different senses with respect to the ontology;
we then annotated each word in the extracted SPC interaction sec-
tions with the corresponding class in the ontology, by assigning a
HTML tag. Active ingredients tagging was performed automati-
cally, by a look-up of terms in Farmadati active ingredients archive.
In particular, we implemented a Java application which, for each
active ingredient in the archive, tests if the text matches it and
then adds the tag. A review of the data has been used to validate
and, when necessary, correct the annotations.
As an example, consider the following sentence (translated
from Italian):
hSalicylatesiDrugClass hmay enhance the effectiInteractionEffect of
horaliIntakeRoute hhypoglycemic agentsiDrugClass, heptiﬁbatideiActive-
DrugIngredient and hsodium valproateiActiveDrugIngredient.
Fig. 1. Excerpt of the ontology concerned with drug-related interactions.
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The feature construction process aims at capturing the salient
characteristics of each token in order to help the system to predict
its semantic label. Feature deﬁnition is a critical stage regarding
the success of feature based statistical models such as CRFs and
SVMs.
Deﬁning the feature function involves constructing a set of real-
value features b (x, i) of the observation x at position i in the sen-
tence, to express some characteristics of empirical distribution of
the training data that should also hold of the model distribution
[33]. We will use binary features, an example of such a feature is:
bjðx; iÞ ¼
1 : if the observation at position i is
the word pharmacokinetics
0 : otherwise
8><
>:
We implemented and employed a large variety of informative fea-
tures. What follows is a report on the set of features we used in
our experiments to discriminate between semantically interesting
and uninteresting content.3.4.1. Orthographical features
As a good starting point, our set of machine learning features
consisted of the simplest and most obvious feature set: word iden-
tity features that is the vocabulary from the training data. Further-
more, we added features that indicate whether the current token is
a digit, which is quite useful for identifying Posology entities.3.4.2. Neighboring word features
Words preceding or following a target word may be useful for
modeling the local context. It is clear that the more context words
analyzed, the better and more precise the results become. How-
ever, widening the context window quickly leads to an explosion
of the computational and statistical complexity. For our experi-
ments, we estimated a suitable window size of [3,3]. As an exam-
ple, consider the following three features:b1ðx; iÞ¼
1 : if the observation at
position i is the word
drugs
0 : otherwise
8>><
>>:
b2ðx; iÞ¼
1 : if the observation at
position i1 is the
word avoid
0 : otherwise
8>><
>>:
b3ðx; iÞ ¼
1 : if the observation at position iþ 1 is
the word association
0 : otherwise
8><
>:
Given the sequence ‘‘avoid drugs association’’, they would be active
(i.e., equal to 1) for the middle token ‘‘drugs’’.
3.4.3. Preﬁx features
Some preﬁxes can provide good clues for classifying named
entities. In particular, we identiﬁed a set of words that occur often
with the same label; for example, Italian words starting with ‘‘ef-
fet-’’ (effect) or ‘‘farmacocinetic-’’ (pharmacokinetic) are usually
Interaction Effects, those starting with ‘‘mg-’’ (mg) or ‘‘dos-’’ (dos-
age) or ‘‘giorn-’’ (day) have usually been tagged as Posology, and
so on. Therefore, we also included some preﬁx features. These fea-
tures help the system recognize informative substrings. However,
short preﬁxes are too common to be of any help in classiﬁcation.
In our experience, the acceptable length for a preﬁx varies by
words, and in many cases, the preﬁx coincides with the word root.
3.4.4. Punctuation features
Also notable are punctuation features, which contain some spe-
cial punctuation in sentences. After browsing our corpus, we found
that colon and brackets features might prove helpful. Given a med-
ication in fact, colon is usually preceded by the interacting sub-
stance and followed by the explanation of the speciﬁc interaction
effects. Additionally, round brackets denotes extra information
regarding the words that follow. For each token, the punctuation
features test whether it is preceded or followed by colon or paren-
thesis. These features have been used in conjunction with a token
window equal to the sentence length. This means that punctuation
features for token j contain predicates about the previous j  n
tokens and the following j +m tokens, where n and m are the
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of the sentence, respectively.3.4.5. Dictionary features
In order to have this model beneﬁt from domain-speciﬁc
knowledge, we added semantic features. Farmadati DataBase is
provided with a complete archive of active ingredients. We create
a binary feature for each entry in the active ingredient archive.
Every time a text token coincides with such an entry, the feature
is active, indicating that the token describes an active drug ingre-
dient. For dictionary entries that are multi-token (e.g., the active
ingredient acetylsalicylic acid), all words are required to match
in the input sequence.3.4.6. Part of speech features
Finally, we supposed lexical information might be quite useful
for identifying named entities. Thus, we included features that
indicate the lexical function (also known as part of speech (POS))
of each token. We used TreeTagger, a POS tagger developed by
Schmid [34], to provide POS information.3.5. Discriminative structured prediction
In this section, we consider the problem of designing classiﬁca-
tion algorithms that learn a direct map from input vectors x 2 X to
discrete output variables y 2 Y, based on a training set of input–
output pairs (x1, y1), . . . , (xN, yN) 2 X  Y drawn from some ﬁxed,
but unknown probability distribution. Unlike multi-class classiﬁ-
cation, where the output space consists of a ﬁnite set of scalar vari-
ables, in our case, the elements of Y are structured objects, in
particular sequences of semantic labels, i.e., hInteractionEffect,
ActiveDrugIngredient, . . .i. In order to deal with this kind of output,
we avail ourselves of two discriminative classiﬁers for general
structured and interdependent output variables: linear-chain CRFs
and structured SVMs, a generalization of multi-class classiﬁers. Un-
like generative models, discriminative classiﬁers learn a direct map
from features x to the labels y. They are hence particularly success-
ful in situations in which it is difﬁcult to properly specify class-
conditional densities. This is the case here in which we wish to
incorporate a large variety of interdependent and long-range fea-
tures of the data. The discriminative approach to classiﬁcation
therefore provides crucial modeling freedom.3.5.1. Conditional random ﬁelds and support vector machines
Let X be a sequence of words in a text document, whose values
are observed. Let Y be some sequence of semantic labels whose val-
ues the task requires the model to predict. CRFs and structured
SVMs all learn linear discriminant functions F that acting on both
X and Y, encode the interdependencies in the input–output space.
Being x a novel observation sequence, we can derive a prediction
of the label sequence y by maximizing F over the output variable.
Hence the general form of our classiﬁers h is:
y ¼ hhðxÞ ¼ argmax
y2Y
Fðx; y; hÞ ð1Þ
where h denotes a parameter vector to be estimated from training
data. Based on this formulation, we can consider several learners
that differ in how they choose model parameters.
The underlying idea of CRFs [35] is that of deﬁning as discrim-
inant function a direct model of the conditional probability p (YjX)
distribution over label sequences given a particular observation se-
quence x, without assuming anything about the input distribution
p (X). Linear-chain CRFs deﬁne the conditional probability to be a
normalized product of potential functions, each of the form:exp
X
j
kjtjðyi1; yi; x; iÞ þ
X
k
lkskðyi; x; iÞ
 !
ð2Þ
where tj(yi1, yi, x, i) is a transition feature function of the entire
observation sequence and the labels at positions i and i  1 in the
label sequence; sk(yi, x, i) is a state feature function of the label at
position i and the observation sequence; and h = (lk, kj)j,k. The
parameters are set to maximize the conditional log-likelihood of la-
beled sequences in the training set. As a measure to control overﬁt-
ting, we use a Gaussian regularization term.
Structured SVMs [36] minimize a particular trade-off between
model complexity and empirical risk. Again, the discriminant func-
tion F takes the form hh, w(x, y)i, where h  ,  i denotes the inner
product, w the feature vector function relating input and output,
and h are the model’s parameters. To ﬁnd h, SVMs minimize the
regularized empirical risk:
min
h
khk2 þ C
XN
i¼1
max
y^2Y
Dðyi; y^Þ þ hh;wðxi; y^Þif g  hh;wðxi; yiÞi ð3Þ
The loss function Dðyi; y^Þ indicate how far y^ is from the true output
yi.
The classiﬁers weigh the different features by estimating the
associated parameters. Once the optimal parameter setting has
been found, the models above can predict the label sequence for
a previously unseen input. To achieve this, both classiﬁers solve
the associated inference problem via Viterbi’s algorithm [37]. Our
system uses the MALLET [38] implementation of CRFs and an
implementation by Bordes et al. [39] of SVMs.4. Experimental evaluations
On the following lines, we present our evaluation method for
the task of automatic recognition of drug-related entities.
4.1. Dataset
We created a corpus which consists of 100 manually annotated
interaction sections of specialty medicines for human use. They
have been extracted from monographs found in the Farmadati
Italia Database, which were taken from the original SPCs drawn
up by the producers. This database contains all the references
about the medicines, the para-pharmaceutical, and the homeo-
pathic products existing in Italy and the medical devices, which
can be sold in pharmacies, for a total of about 800.000 recorded
products. The interaction sections were derived using the BDF
(Bancadati Federfarma) software, combined with a preprocessing
algorithm. BDF software enabled the exporting of the monographs
archive as an ASCII text format ﬁle. This ﬁle lists the monographs
lines of each specialty medicines for human and veterinary use
in the database. An alphanumeric code at the beginning of each
line speciﬁes the drug and the section it refers to. A preprocessing
pass over the exported ﬁle allowed us to split it into different ﬁles,
associated with the corresponding medicine and stating the differ-
ent sections in each ﬁle. Moreover, our database may not be prop-
erly hyphenated due to some length constraints: we solved this
problem using an Italian language lexicon [40].
4.2. Evaluation metrics
Wemeasure the performance of our model on the individual la-
bels using the standard evaluation metrics for machine learning
algorithms: recall ((correct extractions)/(gold standard annota-
tions)), precision ((correct extractions)/(total number of extrac-
tions)), and F1-measure (the weighted harmonic mean of recall
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same importance) [41].
We report the results of our experiments showing recognition
scores for the different labels and the overall performance evalua-
tion of the two classiﬁers. Then, dealing with multi-label classiﬁca-
tion, we combined the performance results of the different labels
following two principal approaches. Either we compute their arith-
metic mean, giving equal weight to each of the labels (macro-aver-
aged), or we compute the mean weighting each label by the
number of times they occur in the dataset (micro-averaged).
Macro-averaged metrics are often dominated by the performance
on rare labels while micro-averaged metrics are dominated by
the performance on frequent labels. The two ways of measuring
performance are hence complementary, and both are informative.4.3. Experimental setup
We randomly split the 100 interaction sections into two sets,
one for training containing 60 sections and one for testing 40 sec-
tions. This amounts to a total of 796 input sentences for training
and 457 input sentences for testing. We used cross-validation on
the training sets to determine reasonable parameter settings of
our models. For the linear SVMs, we found the regularization
parameter k = 1 to work well. All SVMs results in this paper have
been produced using 10 passes through the entire training set.
For the variance of the Gaussian regularizer of the CRFs [42], we
used the value 10.5. Results and discussion
The overall results of both the SVMs and the CRFs can be found
in Table 1. In general, our experiments show that the classiﬁers,
with carefully designed features, can identify drug interactions re-
lated information with a resulting overall accuracy of around 91%.
The two models exhibit similar overall performance, without a
clear superiority of one model over the other. Although the data
might contain noise inherent to manual annotation, the learningTable 1
Overall experimental results (in %) of CRFs and SVMs both including and not including th
Model Micro-average
Precision Recall F1-measure
CRF w/ None 91.27 91.35 91.13
CRF w/o None 89.97 81.97 85.56
SVM w/ None 91.46 91.53 91.41
SVM w/o None 83.63 86.25 86.86
Table 2
Performance results (in %) of the two classiﬁers on individual labels.
Label Ntrain Ntest CRF
Precision Rec
ActiveDrug Ingredient 1379 711 97.98 95.
Age Class 8 16 100 56.
ClinicalCondition 33 69 100 66.
DiagnosticTest 96 32 100 31.
Drug Class 1223 939 87.75 76.
IntakeRoute 39 22 90.48 86.
InteractionEffect 1726 1136 87.58 81.
None 12103 6899 91.96 96.
Other Sub stance 97 80 76.47 65.
PharmaceuticalForm 1 0 – –
PhysiologicalCondition 3 0 – –
Posology 418 213 93.17 89.
Recovering Action 874 477 86.41 78.algorithms reach good performance. Expressing the problem of
content extraction in the described machine learning approach is
therefore promising. However, though the rule-based approach is
efﬁcient, it still might be limited when processing complicated
and highly variable text that conveys multiple kind of information.
Note that the values of the macro-averaged metrics are much
lower than the micro-averaged one. The performance differences
between the macro- and micro-averaged results suggest that some
rare labels are often misclassiﬁed, as shown in their low recall in
Table 2. Macro-averaged metrics, in fact, are often dominated by
the performance on rare labels. Table 2 shows the performance re-
sults on the individual labels for all available features, in terms of
precision recall and F1-measure. Overall, labels whose training
examples are scarce suffer from relatively low performance. It is
the labels DiagnosticTest and OtherSubstance that are hardest to ex-
tract. On the other hand, some other labels such as ClinicalCondition
and IntakeRoute, although rare, perform better. Such labels, in fact,
can rely on a more precise deﬁnition, which is an important factor
that contributes to the good performance. Also notable is the
imbalance among the performance of the two models on the label
AgeClass: on the one hand it is a rare label, on the other hand it is
well deﬁned in the texts. An explanation of this gap is left for fu-
ture work.
Moreover, we investigate the inﬂuence of different feature
groups (i.e., orthographical, neighboring word, preﬁx, POS, punctu-
ation, and dictionary features) on the overall classiﬁcation results.
Table 3 looks at the performance when varying the employed set of
feature, averaged over 20 trials. In each trial, the sentences in the
new training set are sampled uniformly at random from the 1200
sentences in the original dataset. Each feature set differs only in
the absence of a particular group, which is speciﬁed in the ﬁrst col-
umn of Table 3. For all evaluations, we tested numerous settings
for the variance of the Gaussian regularizer and found the value
to work best. This is because each feature is, in general, associated
with a parameter. The more parameters the model has, the higher
its degree of freedom and the more likely it is to overﬁt. This means
that in comparing of different feature groups, we should regularize
differently. Particularly, the more features there are, the smallere label None.
Macro-average Overall accuracy
Precision Recall F1-measure
91.98 74.91 80.83 91.34
91.98 72.77 79.51 81.98
91.33 80.32 84.99 91.52
91.19 78.78 84.07 83.63
SVM
all F1-measure Precision Recall F1-measure
64 96.80 97.85 95.92 96.88
25 72.00 100 81.25 89.65
67 80.00 100 72.46 84.03
25 47.62 100 59.38 74.51
25 81.60 88.10 78.81 83.19
36 88.37 90.00 81.82 85.71
95 84.67 86.82 82.92 84.83
38 94.12 92.65 95.77 94.18
00 70.27 71.23 65.00 67.97
– – – –
– – – –
67 91.39 96.48 90.14 93.20
62 82.33 81.45 80.08 80.76
Table 3
Variation in performance (in %) for different features sets.
Feature set Variance CRF SVM
Precision Recall F1-measure Precision Recall F1-measure
All features 10 90.08 90.25 89.91 90.25 90.41 90.23
No POS features 10 89.86 90.00 89.70 90.03 90.13 89.97
No dictionary features 10 88.33 88.43 88.08 88.71 88.83 88.64
No number features 10 89.44 89.57 89.11 89.47 89.59 89.35
No preﬁx features 20 89.93 90.09 89.73 89.77 89.94 89.71
No punctuation features 20 89.63 89.77 89.40 89.58 89.74 89.51
No word identity features 100 88.071 88.36 87.97 88.15 88.39 88.13
No neighboring features 1000 85.88 86.22 85.80 85.83 86.23 85.45
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the box-and-whisker plots of the results on different feature
categories, showing minimal and maximal values as well as inter-
quartile range (IQR) and median. We focus on the micro-averaged
F1-measure. These ﬁgures clearly illustrate that the absence of
neighboring word features to a greater degree, and then wordAll NoPOS NoWord NoNeigh
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which correspond exactly to those listed in the ﬁrst column of Table 3. In this ﬁgure, thidentity feature to a lesser, both worsen the micro-averaged
F1-measure with statistical signiﬁcance. Not surprisingly, the
neighboring word features have been shown to be the most bene-
ﬁcial ones when comparing the different feature sets, additionally
because they represent the large majority of features. On the other
hand, as expected, the effects of POS, number, punctuation,NoPunct NoPref NoNumb NoDict
ures Set
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Fig. 4. CRFs and SVMs performance for varying feature sets.
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especially because there are only few of them. Finally, we studied
the performances of our two models when using only word neigh-
boring and word identity feature, respectively: Fig. 4 shows how
the results considerably decrease with the above mentioned fea-
ture sets. Therefore, although POS, number, punctuation, preﬁxes,
and dictionary features alone might not have a strong effect on
the models performance, they contain information that is comple-
mentary, resulting in a synergy effects when merged.
The described results are comparable to existing systems. Gold
et al. [24], for example, yielded a precision of 94.1% and a recall of
82.5%, Xu et al. [25] reported a F-measure over 90%. It should be
noted, however, that such systems do not extract drug-interaction
information, thus we cannot perform a fully accurate comparison.
The performance of NER systems, in fact, usually changes when
varying the type of information to be extracted. Within the i2b2
NLP challenge, for instance, among all types of medication infor-
mation, duration and reasons were the most difﬁcult to detect
for all systems [26].
A more recent study from Segura-Bedmar et al. [31] has focused
on the same task of drug-interaction extraction. They follow a sim-
ilar SVMs-based approach and yet rely on a corpus of documents
from the DrugBank database. A second aspect is that this approach
differs from our own since it detects only whether or not an inter-
action occurs between a given pair of drugs in a sentence and does
not consider more speciﬁc information about each interaction.
Although this work is hardly comparable with our own, we never-
theless report results: their best method achieves a F1-measure of
60.01%. Our experimental results compare favorably, since they
have a F1-measure of about 91%.6. Conclusions
We have shown that is possible to perform the task of informa-
tion extraction from SPCs using supervised machine learning tech-
niques. Although we have focused on drug interactions, the
encouraging results and the adaptability of the approach we
adopted means that our system has general signiﬁcance for the
extraction of detailed information about drugs (drug targets, con-
traindications, side effects, etc.).
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